Published in AIDS Weekly, June 10th, 2002
"Human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy (HAART) have experienced a dramatic decrease in Pneumocystis carinii pneumonia (PCP), necessitating reassessment of clinical guidelines for prophylaxis," explained Dr. Sue J. Goldie and colleagues at Harvard University, Boston University, and Massachusetts General Hospital in Boston, the U.S. Centers for Disease Control and Prevention in Atlanta, Yale University in New Haven, Connecticut,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.